2795-5001
2795-5001
S2795-50012024000300156
10.24875/pjdv.24000046
Portugal
Portugal
00
09
2024
00
09
2024
82
3
156
166
[
2022
279
159-70
]
[
2016
2
16057
]
[
2014
99
11
]
[
2014
31
545-9
]
[
2017
102
604-12
]
[
2016
106
6-15
]
[
1992
377-84
]
[
2004
19
41-7
]
[
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
2004
81
19-25
]
[
2006
91
4237-45
]
[
2009
91
456-88
]
[
2023
120
767-93
]
[
2021
13
8799
]
[
2018
24
694-709
]
[
2019
17
533-42
]
[
1988
66
165-72
]
[
1993
8
123-8
]
[
1997
18
774-800
]
[
1989
38
1165-74
]
[
2005
83
1454-60
]
[
1984
64
73S-80
]
[
1998
83
2001-5
]
[
1991
72
83-9
]
[
2006
65
137-45
]
[
2006
91
2100-4
]
[
1998
95
14956-60
]
[
2001
75
53-8
]
[
2013
373
29-38
]
[
2017
17
723-33
]
[
1935
29
181-91
]
[
National Institutes of Health
1992
]
[
2012
97
28-36
]
[
2021
106
2436-46
]
[
2018
]
[
2022
12
2045
]
[
2013
98
4565-92
]
[
2015
73
672-90
]
[
1981
140
815-30
]
[
2005
83
1717-23
]
[
2021
13
]
[
2016
152
391-8
]
[
2001
41
202-6
]
[
2004
18
737-54
]
[
2002
16
275-84
]
[
1993
101
4S-9
]
[
2000
21
363-92
]
[
1961
21
1440-7
]
[
2009
16
51-64
]
[
2008
93
1105-20
]
[
2021
32
277-85
]
[
2003
206
57-67
]
[
1993
39
551-6
]
[
2001
45
S70-80
]
[
1977
97
247-54
]
[
1999
40
106-9
]
[
1991
73
590-5
]
[
2004
5
199-203
]
[
2017
35
271-81
]
[
2019
20
339-52
]
[
2023
15
]
[
2020
26
942-60
]
[
2010
16
347-63
]
[
2011
117
6-13
]
[
2016
22
687-708
]
[
2023
11
1567
]
[
2023
15
]
[
2014
20
748-58
]
[
2023
12
6446
]
[
2017
32
1075-91
]
[
2011
117
145-52
]
[
2012
97
225-30.e2
]
[
2019
3
CD007506
]
[
2021
326
2507-18
]
[
2007
22
317-22
]
[
1995
98
104-10
]
[
2023
189
S1-16
]
[
2017
15
93
]
[
2018
23
64-77
]
[
2021
36
296-311
]
[
2023
63
102162
]
[
2020
29
819-30
]
[
2019
80
1509-21
]
[
2023
24
105-20
]
[
2024
109
36
]
[
2001
2
197-201
]
[
2007
46
94-8
]
[
2006
20
9-20
]
[
2014
15
247-66
]
[
2020
10
]
[
2024
20
1006.e1-30
]
[
2018
32
11-22
]
[
2019
104
2875-91
]
[
2023
83
701-15
]
[
2020
83
1298-303
]
[
2020
6
259-67
]
[
2023
13
150-8
]
[
2023
16
1387-406
]